Cargando…

Self‐Reported Health and Outcomes in Patients With Stable Coronary Heart Disease

BACKGROUND: The major determinants and prognostic importance of self‐reported health in patients with stable coronary heart disease are uncertain. METHODS AND RESULTS: The STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) trial randomized 15 828 patients with st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stewart, Ralph A. H., Hagström, Emil, Held, Claes, Wang, Tom Kai Ming, Armstrong, Paul W., Aylward, Philip E., Cannon, Christopher P., Koenig, Wolfgang, López‐Sendón, José Luis, Mohler, Emile R., Hadziosmanovic, Nermin, Krug‐Gourley, Susan, Ramos Corrales, Marco Antonio, Siddique, Saulat, Steg, Philippe Gabriel, White, Harvey D., Wallentin, Lars
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586450/ https://www.ncbi.nlm.nih.gov/pubmed/28862971 http://dx.doi.org/10.1161/JAHA.117.006096

Ejemplares similares

Body Mass Index and Association With Cardiovascular Outcomes in Patients With Stable Coronary Heart Disease – A STABILITY Substudy
por: Held, Claes, et al.
Publicado: (2022)

Cardiovascular and Lifestyle Risk Factors and Cognitive Function in Patients With Stable Coronary Heart Disease
por: Stewart, Ralph A. H., et al.
Publicado: (2019)

Physical activity in patients with stable coronary heart disease: an international perspective
por: Stewart, Ralph, et al.
Publicado: (2013)

Sex Differences in Clinical Characteristics, Psychosocial Factors, and Outcomes Among Patients With Stable Coronary Heart Disease: Insights from the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial
por: Guimarães, Patricia Oliveira, et al.
Publicado: (2017)

Inflammatory Biomarkers Interleukin‐6 and C‐Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial
por: Held, Claes, et al.
Publicado: (2017)

Lipoprotein‐Associated Phospholipase A(2) Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease
por: Wallentin, Lars, et al.
Publicado: (2016)

Dietary patterns and the risk of major adverse cardiovascular events in a global study of high-risk patients with stable coronary heart disease
por: Stewart, Ralph A. H., et al.
Publicado: (2016)

Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study
por: Wallentin, Lars, et al.
Publicado: (2021)

Prediction of Residual Risk by Ceramide‐Phospholipid Score in Patients With Stable Coronary Heart Disease on Optimal Medical Therapy
por: Hilvo, Mika, et al.
Publicado: (2020)

Growth Differentiation Factor 15 at 1 Month After an Acute Coronary Syndrome Is Associated With Increased Risk of Major Bleeding
por: Lindholm, Daniel, et al.
Publicado: (2017)

Temporal trends in cardiovascular risk factors, lifestyle and secondary preventive medication for patients with myocardial infarction attending cardiac rehabilitation in Sweden 2006–2019: a registry-based cohort study
por: Leosdottir, Margret, et al.
Publicado: (2023)

Mortality and Cardiovascular Outcomes in Patients Presenting With Non–ST Elevation Myocardial Infarction Despite No Standard Modifiable Risk Factors: Results From the SWEDEHEART Registry
por: Figtree, Gemma A., et al.
Publicado: (2022)

Physiological respiratory parameters in pre-hospital patients with suspected COVID-19: A prospective cohort study
por: Mälberg, Johan, et al.
Publicado: (2021)

Development and validation of a quantitative Proximity Extension Assay instrument with 21 proteins associated with cardiovascular risk (CVD-21)
por: Siegbahn, Agneta, et al.
Publicado: (2023)

Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study
por: Storey, Robert F., et al.
Publicado: (2014)

Is a unified blood pressure threshold feasible in the current scenario?: Commentary on the article “130/80 mmHg as a unifying hypertension threshold for office brachial, office central and ambulatory daytime brachial blood pressure”
por: Siddique, Saulat
Publicado: (2023)

Treatment and Prognosis of Myocardial Infarction Outside Cardiology Departments
por: Gard, Anton, et al.
Publicado: (2020)

Efficacy and Safety of Vorapaxar in Non–ST‐Segment Elevation Acute Coronary Syndrome Patients Undergoing Noncardiac Surgery
por: van Diepen, Sean, et al.
Publicado: (2015)

Stroke Outcomes With Vorapaxar Versus Placebo in Patients With Acute Coronary Syndromes: Insights From the TRACER Trial
por: Ungar, Leo, et al.
Publicado: (2018)

Continuous chest compressions are associated with higher peak inspiratory pressures when compared to 30:2 in an experimental cardiac arrest model
por: Mälberg, Johan, et al.
Publicado: (2023)

The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation
por: Hijazi, Ziad, et al.
Publicado: (2016)

Endometriosis and cumulative live birth rate after fresh and frozen IVF cycles with single embryo transfer in young women: no impact beyond reduced ovarian sensitivity—a case control study
por: Feichtinger, Michael, et al.
Publicado: (2019)

Live birth, cumulative live birth and perinatal outcome following assisted reproductive treatments using donor sperm in single women vs. women in lesbian couples: a prospective controlled cohort study
por: Wrande, Tove, et al.
Publicado: (2022)

Reduction in Overall Occurrences of Ischemic Events With Vorapaxar: Results From TRACER
por: White, Harvey D., et al.
Publicado: (2014)

Interphysician agreement on subclassification of myocardial infarction
por: Gard, Anton, et al.
Publicado: (2018)

The facial nerve palsy and cortisone evaluation (FACE) study in children: protocol for a randomized, placebo-controlled, multicenter trial, in a Borrelia burgdorferi endemic area
por: Karlsson, Sofia, et al.
Publicado: (2021)

Serum Neurofilament Light Chain in Patients With Atrial Fibrillation
por: Sjölin, Karl, et al.
Publicado: (2022)

Variation in and prognostic importance of troponin T measured using a high-sensitivity assay in clinically stable haemodialysis patients
por: Wolley, Martin, et al.
Publicado: (2013)

Unrecognized myocardial infarctions assessed by cardiovascular magnetic resonance are associated with the severity of the stenosis in the supplying coronary artery
por: Hammar, Per, et al.
Publicado: (2015)

Predictors, Type, and Impact of Bleeding on the Net Clinical Benefit of Long‐Term Ticagrelor in Stable Patients With Prior Myocardial Infarction
por: Magnani, Giulia, et al.
Publicado: (2021)

New oral anticoagulants in addition to single or dual antiplatelet therapy after an acute coronary syndrome: a systematic review and meta-analysis
por: Oldgren, Jonas, et al.
Publicado: (2013)

Risk score to predict serious bleeding in stable outpatients with or at risk of atherothrombosis
por: Ducrocq, Gregory, et al.
Publicado: (2010)

Unrecognized Myocardial Infarction Assessed by Cardiac Magnetic Resonance Imaging – Prognostic Implications
por: Nordenskjöld, Anna M., et al.
Publicado: (2016)

Effects of Hospital-Based Comprehensive Medication Reviews Including Postdischarge Follow-up on Older Patients’ Use of Health Care: A Cluster Randomized Clinical Trial
por: Kempen, Thomas G. H., et al.
Publicado: (2021)

Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and Chronic Obstructive Pulmonary Disease: An Analysis From the Platelet Inhibition and Patient Outcomes (PLATO) Trial
por: Andell, Pontus, et al.
Publicado: (2015)

Epicardial Adipose Tissue Thickness Correlates with the Presence and Severity of Angiographic Coronary Artery Disease in Stable Patients with Chest Pain
por: Picard, Fabien A., et al.
Publicado: (2014)

Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient Outcomes (PLATO) trial
por: James, Stefan K, et al.
Publicado: (2011)

Interleukin‐18 in patients with acute coronary syndromes
por: Åkerblom, Axel, et al.
Publicado: (2019)

Stable Control of Firing Rate Mean and Variance by Dual Homeostatic Mechanisms
por: Cannon, Jonathan, et al.
Publicado: (2017)

Management and clinical outcome of stable coronary artery disease in Austria: Results from 5 years of the CLARIFY registry
por: Lang, Irene M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_f7qdpnl8vl46d3kqkt8h9v8p7v